fig1

Mechanisms of resistance to NAMPT inhibitors in cancer

Figure 1. The three redundant NAD+ synthesis pathways: salvage (green), de novo (blue) and Preiss-Handler (purple). NAD+: Nicotinamide adenine dinucleotide.

Cancer Drug Resistance
ISSN 2578-532X (Online)

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/